Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical study.
Micronutrient deficiencies, especially zinc and vitamin D deficiency, were linked to higher tinea capitis risk and poorer ...
Flatiron Health and Exact Sciences collaborate to use Flatiron's platform for rapid data analysis with the Oncodetect MRD test. The study involves 1350 patients in community settings, focusing on ...
The XGBoost model predicts hyperglycemia risk in psoriasis patients with high accuracy, achieving an AUC of 0.821 in the training set. A web-based calculator was developed to facilitate personalized ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much earlier, in how clinical trials are designed and who they include. As 2025 ...
NEW YORK--(BUSINESS WIRE)--Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research, and Exact Sciences, a leading provider of cancer screening and ...
Power Medicine, a company revolutionizing oncology drug development, and AdventHealth, a faith-based health system focused on whole-person care, today announced a strategic collaboration to make ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. (“Syapse”), a pioneer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback